| Literature DB >> 32734222 |
Laura Nishi1, Craig Langman2,3, Cybele Ghossein4.
Abstract
Entities:
Year: 2019 PMID: 32734222 PMCID: PMC7380408 DOI: 10.1016/j.xkme.2019.07.012
Source DB: PubMed Journal: Kidney Med ISSN: 2590-0595
Transition Participants Characteristics
| Participants in Transition Program (n =75) | |
|---|---|
| Women | 37 (49%) |
| Men | 38 (51%) |
| Age range at enrollment, y | 18-21 |
| Diagnoses | |
| Glomerulonephritis | 20 |
| Urologic disorders | 17 |
| Hypertension/fibromuscular dysplasia | 10 |
| Genetic tubular interstitial disorders | 7 |
| Nonkidney organ transplant–related CKD | 6 |
| Chemotherapy-related CKD | 4 |
| Polycystic kidney disease | 4 |
| Type 1 DM with microalbuminuria | 2 |
| Tuberous sclerosis | 2 |
| Hydronephrosis | 1 |
| Alport syndrome | 1 |
| ANCA vasculitis | 1 |
Note: Values expressed as number or number (percent).
Abbreviations: ANCA, antineutrophil cytoplasmic antibody; CKD, chronic kidney disease; DM, diabetes mellitus.
Transition Outcomes
| Outcome | Transition Program Participants (n = 75) |
|---|---|
| Successful transition | 53 (71%) |
| Unsuccessful transition | 12 (16%) |
| Lost to follow-up | 7 (9%) |
| Insurance loss/change | 5 (7%) |
| Pending follow-up | 7 (9%) |
| No longer requiring follow-up | 3 (4%) |
Note: Values expressed as number (percent).